Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
Closed Posted
- Opportunity number
- RFA-AI-24-079
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- 501(c)(3) Nonprofits
- Non-501(c)(3) Nonprofits
- For Profit Organizations
- Small Businesses
- State Governments
- City/Township Governments
- Public or Indian Housing Auth.
- Independent School Districts
- Tribal Organizations (Not Federally Recognized)
- County Governments
- Other
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Private)
- Special District Governments
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
Paragraph 1:
This Federal Grant Opportunity, Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional), is seeking applications from single institutions or consortia to participate in a research program focused on understanding the mechanisms underlying the onset and progression of diseases such as asthma, rhinitis, chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The funding will be provided through the U19 cooperative agreement mechanism by the Department of Health and Human Services' National Institutes of Health. The goal is to conduct integrated clinical and translational research to improve the understanding of disease pathogenesis and provide a rational foundation for new, effective treatments and prevention strategies. Applications are open to a wide range of eligible entities including nonprofits, businesses, tribal organizations, and government entities. The deadline for submitting proposals is June 13, 2025.
Paragraph 2:
The funding for this opportunity is part of the broader Allergy and Infectious Diseases Research program (CFDA 93.855), which typically supports awards ranging from $35,000 to $250,000 annually with project periods spanning 2-5 years. The research is expected to be conducted at the recipient facilities across the United States.
Synopsis
The purpose of this notice of funding opportunity (NOFO) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The overarching goal of the program is to improve the understanding of the pathogenesis of these conditions and to provide a rational foundation for new, effective treatments and prevention strategies.
Files
| File | Type | Posted |
|---|---|---|
| RFA-AI-24-079-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity